DexCom (DXCM) PT Raised to $410 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.76 --0%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
Morgan Stanley analyst David Lewis raised the price target on DexCom (NASDAQ: DXCM) to $410.00 (from $402.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Ollie's Bargain Outlet (OLLI) PT Lowered to $113 at Piper Sandler, 'Favorable Risk/Reward for 2H '
- Lendlease Global Commercial REIT (LREIT:SP) PT Lowered to SGD4.50 at JPMorgan
- Audinate Group Ltd (AD8:AU) PT Lowered to AUD5.25 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
